This Week at FDA: Remote regulatory assessments guidance, 12-digit NDCs, and more
This Week at FDAMichael Mezher
BiologicsBiotechnologyDiagnosticsMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/PolicyThis Week at FDAMichael MezherBiologicsBiotechnologyDiagnosticsMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy